Moderna started a phase 1 trial of an mRNA vaccine against Bundibugyo ebolavirus, a strain for which no vaccine is approved, that is driving an outbreak in Congo.
Moderna Begins First Human Trial of a Vaccine for the Ebola Strain Driving Congo’s Outbreak
by | Aug 13, 2026 | Uncategorized | 0 comments
Recent Comments